Enterprise honor of Tianjin Hongri Pharmaceutical Co., Ltd.

20 12 12 The trademark Xuebijing of Hongri Pharmaceutical was recognized as a well-known trademark by the Trademark Office of the State Administration for Industry and Commerce. 20 12 12 Hongri Pharmaceutical won the Tianjin Patent Excellence Award.

(patent name: a quality inspection method of Xuebijing injection) 2065438+February 2003 Hongri Pharmaceutical successfully passed GMP certification and obtained GMP certificate. March 20 13 Hongri Pharmaceutical won the first prize of Tianjin Science and Technology Progress Award (project name: key technology and application of secondary development of Chinese patent medicine). On March 20 13, Hongri Pharmaceutical won the second prize of Tianjin Science and Technology Progress (project name: innovative drug research and development project focusing on the transformation and industrialization of scientific and technological achievements). 201may 3. Won the honor of "Top 100 Capital Brand Premium of Listed Companies in China in 20 13". August 20 13, Hongri Pharmaceutical ranked seventh among the top 20 most competitive pharmaceutical listed companies in China.

Won 20 13 top 20 values of listed companies in China growth enterprise market and 10 value.

Won the "20 13 Best Board of Directors of Listed Companies in China Small and Medium-sized Board and Growth Enterprise Market".

Founder Yao Xiaoqing was awarded "20 13 Chairman of the Most Respected Listed Company in China".